IND filed for AVP-923 for central neuropathic pain in MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

IND filed for AVP-923 for central neuropathic pain in MS

Postby MSUK » Mon Apr 04, 2011 8:02 am

Image


Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS).

The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... geid/1310/
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2091
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users